A randomized phase 2 trial of CRLX101 in combination with bevacizumab in patients with metastatic renal cell carcinoma (mRCC) versus standard of care (SOC) Meeting Abstract
| Authors: | Voss, M.; Hutson, T. E.; Hussain, A.; Vaishampayan, U.; Vogelzang, N. J.; Crowell, T.; Li, J.; Downing, W.; Senderowicz, A.; Stone, E. |
| Abstract Title: | A randomized phase 2 trial of CRLX101 in combination with bevacizumab in patients with metastatic renal cell carcinoma (mRCC) versus standard of care (SOC) |
| Meeting Title: | 15th International Kidney Cancer Symposium |
| Journal Title: | BJU International |
| Volume: | 118 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2016 Nov 4-5 |
| Meeting Location: | Miami, FL |
| ISSN: | 1464-4096 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2016-12-01 |
| Start Page: | 5 |
| End Page: | 6 |
| Language: | English |
| ACCESSION: | WOS:000388478200005 |
| PROVIDER: | wos |
| PUBMED: | 27860174 |
| DOI: | 10.1111/bju.13694 |
| Notes: | Meeting Abstract -- Source: Wos |
